Jun 12, 2015
Safety Labeling Changes for Epilepsy Drugs
Safety Labeling Changes for Epilepsy Drugs
Lamictal (lamotrigine) Tablets, Chewable Dispersible Tablets, and Orally Disintegrating Tablets
[adrotate banner=”3″]
[pullquote align=”right”][adrotate banner=”7″][/pullquote]
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2015
Summary View
BOXED WARNING (edited)
LAMICTALcan cause serious rashes requiring hospitalization and…
View On WordPress